Market closed

Brainstorm Cell Therapeutics/$BCLI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Ticker

$BCLI
Trading on

Industry

Biotechnology

Employees

27

BCLI Metrics

BasicAdvanced
$7.9M
-
-$2.31
0.59
-
$7.9M
0.59
$2.50
$0.72
308K
0.043
0.028
-2.202
-9.274
-151.86%
-241.99%
184.17%
-0.96
-0.96
-0.668
-61.34%
-39.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $BCLI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Brainstorm Cell Therapeutics stock?

What is the P/E ratio for Brainstorm Cell Therapeutics stock?

Does Brainstorm Cell Therapeutics stock pay dividends?

When is the next Brainstorm Cell Therapeutics dividend payment date?

What is the beta indicator for Brainstorm Cell Therapeutics?